Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients

NCT04466826 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04466826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Withdrawn
Start date
January 2, 2021
Completion date
February 5, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine in children, pain, neuropathic